IBA and Jabil Enhance Sterilization Technology Through Partnership

IBA and Jabil Collaborate on Innovative Sterilization Solutions
In an exciting development, IBA (Ion Beam Applications S.A.), renowned for its leadership in particle accelerator technology, has joined forces with Jabil Inc., a global leader in manufacturing and supply chain solutions. This collaboration marks a significant step forward in sterilization technology, particularly with the installation of a state-of-the-art Be-Wide X-ray solution.
About the Be-Wide X-ray Solution
The Be-Wide X-ray system, powered by IBA's advanced Rhodotron accelerator, is set to revolutionize sterilization capabilities. This innovative solution is designed for a greenfield site in Byhalia, aimed at greatly enhancing Jabil’s production strength in medical product sterilization. It encompasses a comprehensive range of features, including a full-size pallet conveyor and a Beagle production line control system, ensuring efficient operations.
Key Features of the Be-Wide X-ray Solution
One of the main attractions of the Be-Wide X-ray solution is its advanced sterilization technology, which caters to various medical devices. This solution is not just about meeting basic sterilization needs; it represents a leap into high-scale production integrated with cutting-edge technology that guarantees safety and compliance.
This significant investment ensures that Jabil is well-equipped to satisfy the growing demands for effective sterilization methods globally. With high operational standards, this new system allows for meticulous sterilization cycle documentation and integrated logistics and procurement.
Future Developments and Timeline
The construction of the new facility at Jabil is set to wrap up during the latter half of 2026, with expectations for the Be-Wide X-ray system to be fully operational by late 2027. IBA will handle the installation, testing of the equipment, and the training of Jabil’s personnel ensuring a seamless integration into their operations.
Insights from Jabil and IBA Executives
Mike Mahaz, Senior Vice President of the Healthcare Division at Jabil, expressed his enthusiasm about this partnership. He stated, “Jabil is pleased to partner with IBA to expand our sterilization services with industrial X-ray irradiation. IBA’s expertise ensures our X-ray services will operate with utmost care and quality.” This sentiment echoes the forward-thinking approach both companies have embraced.
Thomas Servais, President of IBA Industrial Solutions, remarked, “We are proud to support Jabil Healthcare on this transformative step. Our Be-Wide X-ray Solution not only expands their global sterilization capabilities but ensures they stay at the forefront of technology to meet the ever-evolving demands of the medical device industry.”
Investment and Costs
The investment required for a Be-Wide X-ray solution can vary widely, typically ranging from EUR 16 million to EUR 19 million depending on specific configurations and options selected. This strategic investment will position Jabil as a leader in the sterilization market, allowing for enhanced production capabilities.
About IBA
IBA (Ion Beam Applications S.A.) leads the field in particle accelerator technology, providing exceptional equipment and services for proton therapy and industrial sterilization. With its headquarters located in Belgium, IBA employs a passionate workforce of approximately 2,000 individuals committed to excellence and innovation.
About Jabil
Operating with over 50 years of industry experience, Jabil (NYSE: JBL) prides itself on being a partner for top global brands, offering tailored engineering and manufacturing solutions. Jabil's extensive global network enables it to implement both scalable and customized solutions while championing sustainability and community development.
Frequently Asked Questions
What is the Be-Wide X-ray solution?
The Be-Wide X-ray solution is an advanced sterilization technology designed to enhance Jabil's production capabilities for medical devices.
When is the Jabil facility expected to start operations?
The new facility is set to achieve full operational capability for the Be-Wide solution by late 2027.
How much does the Be-Wide X-ray solution typically cost?
The investment for a Be-Wide X-ray solution typically ranges from EUR 16 million to EUR 19 million based on configuration and options.
What are the key features of the Be-Wide system?
Key features include a full-size pallet conveyor, Beagle production line control, and stringent safety and compliance protocols.
Where is IBA based?
IBA is headquartered in Louvain-la-Neuve, Belgium, and employs around 2,000 staff worldwide.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.